Dietary supplementation with shiikuwasha extract attenuates dexamethasone-induced skeletal muscle atrophy in aged rats
Autor: | Hirohiko Nakamura, Yasuhiro Takeda, Kazuyoshi Namba, Fumiaki Yoshizawa, Tomoyuki Okamoto, Yasuyuki Sakata, Kazutaka Oshio, Hiroshi Iwamoto |
---|---|
Rok vydání: | 2015 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Shiikuwasha Multidisciplinary business.industry Research Polymethoxylated flavones 03 medical and health sciences 030104 developmental biology Endocrinology Glucocorticoid Internal medicine Grape extract medicine Rat Dietary supplementation business Dexamethasone Skeletal muscle atrophy medicine.drug |
Zdroj: | SpringerPlus |
ISSN: | 2193-1801 |
Popis: | Background Skeletal muscle atrophy is caused by a variety of diseases and conditions. In particular, skeletal muscle atrophy in the elderly contributes to a loss of independence with advanced age and increases the risk of falling. However, the effect of food consumed on a daily basis on skeletal muscle atrophy has been the focus of little research. In this study, the effects of dietary supplementation with shiikuwasha extract or grape extract on dexamethasone-induced skeletal muscle atrophy were evaluated in aged rats. Methods Aged male rats (15-month-old) were fed a diet supplemented with either 1 % shiikuwasha extract or 1 % grape extract for 19 days. During the last 5 days of the feeding period, rats were injected with dexamethasone to induce muscle atrophy. Results Body weight and hind-limb muscle weight were significantly decreased by dexamethasone treatment. The supplementation of shiikuwasha extract showed no effect on body weight loss, but markedly attenuated tibialis anterior muscle weight loss induced by dexamethasone. On the other hand, grape extract did not affect muscle weight loss. Furthermore, shiikuwasha extract significantly reduced dexamethasone-induced expression of atrogin-1 and MuRF1 mRNA, but did not reduce LC3B-II protein levels. Conclusion These results suggest that shiikuwasha extract may partially inhibit the activation of the ubiquitin–proteasome system and may consequently attenuate skeletal muscle atrophy induced by dexamethasone in aged rats. |
Databáze: | OpenAIRE |
Externí odkaz: |